David Shapiro - CEO of B2i Digital
@b2idigital.bsky.social
B2i Digital executes targeted digital marketing campaigns to generate investor awareness for public companies. David Shapiro is the Founder & CEO. b2idigital.com
Pinned
Applied Energetics, Inc. (OTCQB: AERG), a pioneer in ultrashort pulse laser (USPL) and advanced directed energy solutions, has appointed Dr. Matthew Seaford to its Advisory Board. He brings more than three decades of leadership in advanced technology, national security
B2i Digital is pleased to announce MISTRAS Group Inc. (NYSE - MG) is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
November 14, 2025 at 11:17 PM
B2i Digital is pleased to announce MISTRAS Group Inc. (NYSE - MG) is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
B2i Digital Digital is pleased to announce Aeries Technology, Inc. (Nasdaq: AERT) is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
November 14, 2025 at 10:52 PM
B2i Digital Digital is pleased to announce Aeries Technology, Inc. (Nasdaq: AERT) is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
eXoZymes (Nasdaq: EXOZ) Inc. (NASDAQ: EXOZ) announced its Q3 operational update for the fiscal quarter ended October 31, 2025.
eXoZymes Inc is a B2i Digital Featured Company. See their full profile at b2idigital.com/exozymes-1.
eXoZymes Inc is a B2i Digital Featured Company. See their full profile at b2idigital.com/exozymes-1.
November 14, 2025 at 10:00 PM
eXoZymes (Nasdaq: EXOZ) Inc. (NASDAQ: EXOZ) announced its Q3 operational update for the fiscal quarter ended October 31, 2025.
eXoZymes Inc is a B2i Digital Featured Company. See their full profile at b2idigital.com/exozymes-1.
eXoZymes Inc is a B2i Digital Featured Company. See their full profile at b2idigital.com/exozymes-1.
B2i Digital Digital is pleased to announce Aeva Technologies, Inc. (NASADQ: AEVA) is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
November 14, 2025 at 9:25 PM
B2i Digital Digital is pleased to announce Aeva Technologies, Inc. (NASADQ: AEVA) is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
B2i Digital Digital is pleased to announce Bakkt Holdings, Inc. (NYSE: BKKT) is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
November 14, 2025 at 9:13 PM
B2i Digital Digital is pleased to announce Bakkt Holdings, Inc. (NYSE: BKKT) is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
B2i Digital Digital is pleased to announce Aware, Inc. is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
November 14, 2025 at 4:23 PM
B2i Digital Digital is pleased to announce Aware, Inc. is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
B2i Digital is pleased to announce Curiosity Stream is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
November 14, 2025 at 4:06 PM
B2i Digital is pleased to announce Curiosity Stream is participating in the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18–19, 2025, at the Hard Rock Hotel in New York, NY.
Intuitive Machines, Inc. (Nasdaq: LUNR) is pleased to participate in the 14th Annual ROTH Capital Partners Technology Conference on Nov 18–19 at the Hard Rock Hotel in NYC.
The 14th Annual ROTH Technology Conference is a B2i Digital Featured Conference. Details at: lnkd.in/egQhK7wU
The 14th Annual ROTH Technology Conference is a B2i Digital Featured Conference. Details at: lnkd.in/egQhK7wU
November 14, 2025 at 3:45 PM
Intuitive Machines, Inc. (Nasdaq: LUNR) is pleased to participate in the 14th Annual ROTH Capital Partners Technology Conference on Nov 18–19 at the Hard Rock Hotel in NYC.
The 14th Annual ROTH Technology Conference is a B2i Digital Featured Conference. Details at: lnkd.in/egQhK7wU
The 14th Annual ROTH Technology Conference is a B2i Digital Featured Conference. Details at: lnkd.in/egQhK7wU
Unicycive Therapeutics (Nasdaq: UNCY) announced Q3 2025 results and remains on track to resubmit its NDA for oxylanthanum carbonate (OLC) by year-end.
Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at b2idigital.com/unicycive.
Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at b2idigital.com/unicycive.
November 12, 2025 at 5:35 PM
Unicycive Therapeutics (Nasdaq: UNCY) announced Q3 2025 results and remains on track to resubmit its NDA for oxylanthanum carbonate (OLC) by year-end.
Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at b2idigital.com/unicycive.
Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at b2idigital.com/unicycive.
Xtant Medical Holdings (NYSE American: XTNT) reported Q3 2025 results with revenue of $33.3 million, up 19% year-over-year, achieving net income of $1.3 million compared to a net loss of $5.0 million in Q3 2024.
Xtant Medical is a B2i Digital Featured Company. b2idigital.com/xtant-medical.
Xtant Medical is a B2i Digital Featured Company. b2idigital.com/xtant-medical.
November 12, 2025 at 5:18 PM
Xtant Medical Holdings (NYSE American: XTNT) reported Q3 2025 results with revenue of $33.3 million, up 19% year-over-year, achieving net income of $1.3 million compared to a net loss of $5.0 million in Q3 2024.
Xtant Medical is a B2i Digital Featured Company. b2idigital.com/xtant-medical.
Xtant Medical is a B2i Digital Featured Company. b2idigital.com/xtant-medical.
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) announced that leading independent proxy advisory firms have both recommended shareholders vote AGAINST the Share Limit Resolution at the November 25, 2025 special meeting.
The complete news release: kolibrienergy.com/independent-...
The complete news release: kolibrienergy.com/independent-...
November 12, 2025 at 4:41 PM
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) announced that leading independent proxy advisory firms have both recommended shareholders vote AGAINST the Share Limit Resolution at the November 25, 2025 special meeting.
The complete news release: kolibrienergy.com/independent-...
The complete news release: kolibrienergy.com/independent-...
For investors seeking maritime exposure, Heidmar Inc. Maritime Holdings Corp.'s (NASDAQ: HMR) CEO Pankaj Khanna articulates how the company's asset-light model transforms shipping volatility into opportunity.
November 10, 2025 at 10:52 PM
For investors seeking maritime exposure, Heidmar Inc. Maritime Holdings Corp.'s (NASDAQ: HMR) CEO Pankaj Khanna articulates how the company's asset-light model transforms shipping volatility into opportunity.
Applied Energetics, Inc. (OTCQB: AERG), a pioneer in ultrashort pulse laser (USPL) and advanced directed energy solutions, has appointed Dr. Matthew Seaford to its Advisory Board. He brings more than three decades of leadership in advanced technology, national security
November 10, 2025 at 10:43 PM
Applied Energetics, Inc. (OTCQB: AERG), a pioneer in ultrashort pulse laser (USPL) and advanced directed energy solutions, has appointed Dr. Matthew Seaford to its Advisory Board. He brings more than three decades of leadership in advanced technology, national security
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) will participate in two virtual non-deal roadshows on November 13, 2025, giving investors an opportunity to hear directly from the company’s leadership.
November 10, 2025 at 8:56 PM
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) will participate in two virtual non-deal roadshows on November 13, 2025, giving investors an opportunity to hear directly from the company’s leadership.
The B2i Digital team is pleased to introduce SuperCom (NASDAQ: SPCB) as a new B2i Digital Featured Company. A full company profile will be available soon at b2idigital.com/featured-com....
November 10, 2025 at 6:32 PM
The B2i Digital team is pleased to introduce SuperCom (NASDAQ: SPCB) as a new B2i Digital Featured Company. A full company profile will be available soon at b2idigital.com/featured-com....
B2i Digital is proud to serve, once again, as the Marketing Partner for the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18-19, 2025, at the Hard Rock Hotel in New York, NY.
See more details at: lnkd.in/egQhK7wU
See more details at: lnkd.in/egQhK7wU
November 10, 2025 at 4:14 PM
B2i Digital is proud to serve, once again, as the Marketing Partner for the 14th Annual ROTH Capital Partners Technology Conference, taking place November 18-19, 2025, at the Hard Rock Hotel in New York, NY.
See more details at: lnkd.in/egQhK7wU
See more details at: lnkd.in/egQhK7wU
Heidmar Inc. Maritime Holdings Corp. (NASDAQ: HMR) reported third quarter 2025 results, highlighted by substantial revenue growth, expansion of its managed fleet, and continued advancements in its integrated maritime platform.
November 7, 2025 at 7:07 PM
Heidmar Inc. Maritime Holdings Corp. (NASDAQ: HMR) reported third quarter 2025 results, highlighted by substantial revenue growth, expansion of its managed fleet, and continued advancements in its integrated maritime platform.
Applied Energetics, Inc. (OTCQB: AERG), announced that CEO Chris Donaghey will moderate a panel titled “Transforming Warfighting: DefenseTech Disruption” at the 8th Annual Baird Defense & Government Conference on Tuesday, November 18, 2025 at 3:55 pm ET at The Ritz-Carlton, Tysons Corner, Virginia.
November 6, 2025 at 7:58 PM
Applied Energetics, Inc. (OTCQB: AERG), announced that CEO Chris Donaghey will moderate a panel titled “Transforming Warfighting: DefenseTech Disruption” at the 8th Annual Baird Defense & Government Conference on Tuesday, November 18, 2025 at 3:55 pm ET at The Ritz-Carlton, Tysons Corner, Virginia.
Heidmar Inc. Maritime Holdings Corp. (NASDAQ: HMR) announced the addition of a super-eco LR2 tanker to its managed fleet under commercial and technical management agreements, with the vessel scheduled to join the fleet in December 2025.
November 5, 2025 at 10:07 PM
Heidmar Inc. Maritime Holdings Corp. (NASDAQ: HMR) announced the addition of a super-eco LR2 tanker to its managed fleet under commercial and technical management agreements, with the vessel scheduled to join the fleet in December 2025.
Xtant Medical Holdings (NYSE-American: XTNT) announced the commercial launch of CollagenX™, its bovine collagen particulate product for surgical wound closure, and scheduled its Q3 2025 financial results announcement for November 11, 2025.
November 5, 2025 at 9:22 PM
Xtant Medical Holdings (NYSE-American: XTNT) announced the commercial launch of CollagenX™, its bovine collagen particulate product for surgical wound closure, and scheduled its Q3 2025 financial results announcement for November 11, 2025.
Unicycive Therapeutics (Nasdaq: UNCY) announced that CEO Dr. Shalabh Gupta, MD Gupta will participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on Monday, November 10, 2025, at 3:30 p.m. ET.
November 3, 2025 at 11:19 PM
Unicycive Therapeutics (Nasdaq: UNCY) announced that CEO Dr. Shalabh Gupta, MD Gupta will participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on Monday, November 10, 2025, at 3:30 p.m. ET.
Addressing questions about capital structure, Heidmar Inc. Maritime Holdings Corp.'s (NASDAQ: HMR) CEO Pankaj Khanna clarifies the purpose and structure of the company's $20 million B. Riley facility.
November 3, 2025 at 9:10 PM
Addressing questions about capital structure, Heidmar Inc. Maritime Holdings Corp.'s (NASDAQ: HMR) CEO Pankaj Khanna clarifies the purpose and structure of the company's $20 million B. Riley facility.
Spartan Capital Securities, LLC and B2i Digital are pleased to announce that CORE IR & PR is a Supporting Tier Sponsor of the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.
October 31, 2025 at 9:20 PM
Spartan Capital Securities, LLC and B2i Digital are pleased to announce that CORE IR & PR is a Supporting Tier Sponsor of the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.
Unicycive Therapeutics (Nasdaq: UNCY) announced the upcoming presentation of new data at ASN Kidney Week 2025 demonstrating that oxylanthanum carbonate (OLC) dramatically reduces pill burden for dialysis patients with hyperphosphatemia.
October 30, 2025 at 9:37 PM
Unicycive Therapeutics (Nasdaq: UNCY) announced the upcoming presentation of new data at ASN Kidney Week 2025 demonstrating that oxylanthanum carbonate (OLC) dramatically reduces pill burden for dialysis patients with hyperphosphatemia.
Unicycive Therapeutics (Nasdaq: UNCY) announced FDA alignment on resolving the single manufacturing deficiency delaying approval of its novel phosphate binder Oxylanthanum Carbonate (OLC).
Unicycive Therapeutics is a B2i Digital Featured Company. View their profile at b2idigital.com/unicycive.
Unicycive Therapeutics is a B2i Digital Featured Company. View their profile at b2idigital.com/unicycive.
October 30, 2025 at 9:14 PM
Unicycive Therapeutics (Nasdaq: UNCY) announced FDA alignment on resolving the single manufacturing deficiency delaying approval of its novel phosphate binder Oxylanthanum Carbonate (OLC).
Unicycive Therapeutics is a B2i Digital Featured Company. View their profile at b2idigital.com/unicycive.
Unicycive Therapeutics is a B2i Digital Featured Company. View their profile at b2idigital.com/unicycive.